Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Why CRISPR babies are still too risky — embryo studies highlight challenges

While society grapples with the social and ethical implications of heritable genome editing, technical obstacles still abound.
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

More than four years after the first children with edited genomes were born, genome-editing techniques are still not safe enough to be used in human embryos that are destined for reproduction, organizers of the Third International Summit on Human Genome Editing announced at the conclusion of the meeting.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 615, 568-569 (2023)

doi: https://doi.org/10.1038/d41586-023-00756-0

References

  1. Alanis-Lobato, G. et al. Proc. Natl Acad. Sci. USA 118, e2004832117 (2021).

    Article  PubMed  Google Scholar 

  2. Liang, D. et al. Nature Commun. 14, 1219 (2023).

    Article  PubMed  Google Scholar 

  3. Kang, Y. et al. Sci. Adv. 8, eabo3123 (2022).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links